For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
Disc Medicine Inc (NASDAQ: IRON) closed the day trading at $42.58 down -12.40% from the previous closing price of $48.60. In other words, the price has decreased by -$12.40 from its previous closing price. On the day, 0.8 million shares were traded.
Ratios:
For a better understanding of IRON, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 21.17 and its Current Ratio is at 21.17. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.07.
On November 05, 2024, Morgan Stanley Upgraded its rating to Overweight which previously was Equal-Weight but kept the price unchanged to $85.
Raymond James Upgraded its Outperform to Strong Buy on November 04, 2024, whereas the target price for the stock was revised from $66 to $110.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 02 ’25 when Savage William Jacob sold 2,100 shares for $50.17 per share. The transaction valued at 105,367 led to the insider holds 66,398 shares of the business.
WILLIAM SAVAGE bought 8,777 shares of IRON for $436,041 on May 02 ’25. On Mar 24 ’25, another insider, Ashiya Mona, who serves as the Director of the company, sold 5,738 shares for $54.11 each. As a result, the insider received 310,483 and left with 186,541 shares of the company.
Stock Price History:
Over the past 52 weeks, IRON has reached a high of $68.73, while it has fallen to a 52-week low of $28.25. The 50-Day Moving Average of the stock is -12.30%, while the 200-Day Moving Average is calculated to be -19.12%.
Shares Statistics:
A total of 29.87M shares are outstanding, with a floating share count of 21.87M. Insiders hold about 36.86% of the company’s shares, while institutions hold 52.40% stake in the company.
Earnings Estimates
The current rating of Disc Medicine Inc (IRON) reflects the combined expertise of 8.0 analysts actively engaged in assessing its market performance.The consensus estimate for the next quarter is -$1.17, with high estimates of -$0.96 and low estimates of -$1.61.
Analysts are recommending an EPS of between -$4.08 and -$5.94 for the fiscal current year, implying an average EPS of -$4.89. EPS for the following year is -$5.39, with 9.0 analysts recommending between -$3.56 and -$8.45.
